Work Area: Transactions

Latest content

Intel’s mega monetisation deal with IPValue may raise eyebrows but makes perfect sense

The chipmaker spawned the term “patent troll” and has been highly critical of NPEs, but negative business headwinds mean that putting its world-class portfolio of IP assets to work is a no brainer

19 August 2022

The five hub-and-spokes models transforming pharma IP commercialisation

Several approaches have emerged under this banner, each offering advantages and disadvantages

15 August 2022

Musk v Twitter is a reminder that brands must be prepared for targeting by passionate fan bases

The unfolding legal dispute between the ubiquitous social media giant and the billionaire with 100 million followers is set to become the legal battle of the year when it hits court in October

13 August 2022

Pfizer and Amgen fight to avoid patent cliff falls in multi-billion dollar buying sprees

With significant revenue drop-offs from existing branded products set to decline steeply in the second half of this decade, major portfolio acquisitions are a priority for both companies

10 August 2022

IPBC Asia all set for Tokyo this autumn

The Asia-Pacific region’s premier event about the business of IP will take place in the Japanese capital from 31 October to 2 November

10 August 2022

Intel transfers 5,000 assets to IPValue in major patent deal

The portfolio covers a wide range of the tech produced by the Silicon Valley giant and will now be monetised by an entity named Tahoe Research Limited

08 August 2022

The contribution patents make to enterprise value

No commonly used valuation methods are much help at putting a number on an entire portfolio unless there is a specific transaction on the horizon. Cipher’s Nigel Swycher and Steve Harris suggest an original methodology to fill this gap

03 August 2022

Sanofi farms out more IP as part of “play to win” strategy

The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months

29 July 2022

Be proactive about IP ownership

Employees are not necessarily always renumerated for their patented or patentable inventions. Therefore, employers are advised to take a number of steps to avoid disruptive issues over the ownership of intellectual property created by their employees.

27 July 2022

UK government blocks IP deal with Chinese company using radical new powers

Recently implemented legislation gives the British government the ability to intervene in IP transactions

22 July 2022

Unlock unlimited access to all IAM content